DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹9,053 Cr | ₹8,629 Cr | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr |
What is the latest Net Current Assets ratio of DIVIS LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹9,053 Cr |
| Mar2025 | ₹8,629 Cr |
| Mar2024 | ₹8,397 Cr |
| Mar2023 | ₹8,211 Cr |
| Mar2022 | ₹7,156 Cr |
How is Net Current Assets of DIVIS LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹9,053 Cr | 4.91 | |
| Mar2025 | ₹8,629 Cr | 2.76 | |
| Mar2024 | ₹8,397 Cr | 2.27 | |
| Mar2023 | ₹8,211 Cr | 14.74 | |
| Mar2022 | ₹7,156 Cr | - | |
Compare Net Current Assets of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹241,605.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
| MANKIND PHARMA | ₹96,179.6 Cr | -2.9% | -4.2% | -6.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.6% |
9.8% |
51.8% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses